Lv1
40 积分 2024-04-22 加入
Interim analysis of the PARADISE study: benefits of add-on peginterferon-α in NA-treated patients with CHB
4个月前
已完结
Topoisomerase I inhibitors: Challenges, progress and the road ahead
6个月前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
6个月前
已完结
Targeting chromosomal instability in patients with cancer
7个月前
已完结
Abstract 486: A phase Ib/II, open-label study evaluating the efficacy and safety of Toripalimab injection (JS001) or combination with Lenvatinib as a neoadjuvant therapy for patients with resectable hepatocellular carcinoma (HCC)
7个月前
已关闭
The balance of STING signaling orchestrates immunity in cancer
7个月前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
7个月前
已完结
Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: A nationwide Taiwan database analysis of long‐term outcome predictors
7个月前
已完结
Prognostic Factors in High-Grade Osteosarcoma of theExtremities or Trunk: An Analysis of 1,702 Patients Treatedon Neoadjuvant Cooperative Osteosarcoma Study GroupProtocols
10个月前
已完结
皖公网安备34019202002308
